EHA Library - The official digital education library of European Hematology Association (EHA)

NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET COUNT AS PROGNOSTIC INDEX IN MYELODYSPLASTIC SYNDROME
Author(s): ,
Inga Mandac Rogulj
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
,
Karla Mišura
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
,
Nika Popović
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
,
Bojana Ačamović Stipinović
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
,
Ana Beganović
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
Slobodanka Ostojić Kolonić
Affiliations:
Clinical Hospital Merkur, Zagreb,Zagreb,Croatia
(Abstract release date: 05/17/18) EHA Library. MANDAC ROGULJ I. 06/14/18; 216366; PB2111
Inga MANDAC ROGULJ
Inga MANDAC ROGULJ
Contributions
Abstract

Abstract: PB2111

Type: Publication Only

Background

Inflammatory and immune response in tumor microenvironment  is important in the pathophysiology of tumor progression, and has been studied so far in many solid tumors and haematological malignancies. In tumor microenvironment, neutrophils secrete different cytokines that stimulate tumor growth, while lymphocytes represent immune defense against tumor cells and mediate cytotoxic cell death .  Absolute neutrophil to lymphocyte ratio (NLR) was previously analyzed as prognostic parameter in solid tumors and haematological disorders.  Thrombocytopenia is a known hematologic parameter of poor survival in patients with myelodysplastic syndrome (MDS). In this work, we tried to determine the prognostic significance of NLR and platelet count in MDS patient group. 

 

Aims

In the retrospective cohort of 58 untreated MDS patients, we analyzed clinical and laboratory data of MDS patients and the prognostic significance of the NLR and platelet count in correlation with well known prognostic indices (IPSS, IPSSR). 

 

Methods

The study included 58 patients (24 women, 34 males), median age 73 years. Patients with IPSS <1.5 had significantly higher platelet count compared to those with IPSS> 1.5 (138 vs. 58, p <0.001),  as well as in the R-IPSS group <4.5 versus those in the group with R-IPSS> 4.5 (122 vs. 68, p <0.01). 

 

Results

No statistically significant difference in NLR (p <0.087 for IPSS or p <0.112 for R-IPSS) was found. The number of platelets showed a negative correlation with IPSS (rho = -0.500, p <0.001) and R-IPSS (rho = -0.456, p <0.001). Analyzing other parameters, statistically significant correlation of IPSS with LDH (p <0.008) and CRP (p <0.01) was observed. In the IPSS group <1.5 there was a significantly lower LDH level compared to patients with IPSS> 1.5 (189 vs. 233) as well as for CRP (3.25 vs. 11.05) The same observation was for R-IPSS (for LDH 189.5 vs. 227.5, p <0.01, for CRP 2.55 vs 12.1, p <0.002). 

 

Conclusion

In a small number of our patients, we have shown that platelet count, LDH and CRP,  have negative correlation with IPSS and R-IPSS prognostic index.  NLR was not statistically significant, but this should be analyzed on a larger number of MDS patients.

 

Session topic: 10. Myelodysplastic syndromes – Clinical

Abstract: PB2111

Type: Publication Only

Background

Inflammatory and immune response in tumor microenvironment  is important in the pathophysiology of tumor progression, and has been studied so far in many solid tumors and haematological malignancies. In tumor microenvironment, neutrophils secrete different cytokines that stimulate tumor growth, while lymphocytes represent immune defense against tumor cells and mediate cytotoxic cell death .  Absolute neutrophil to lymphocyte ratio (NLR) was previously analyzed as prognostic parameter in solid tumors and haematological disorders.  Thrombocytopenia is a known hematologic parameter of poor survival in patients with myelodysplastic syndrome (MDS). In this work, we tried to determine the prognostic significance of NLR and platelet count in MDS patient group. 

 

Aims

In the retrospective cohort of 58 untreated MDS patients, we analyzed clinical and laboratory data of MDS patients and the prognostic significance of the NLR and platelet count in correlation with well known prognostic indices (IPSS, IPSSR). 

 

Methods

The study included 58 patients (24 women, 34 males), median age 73 years. Patients with IPSS <1.5 had significantly higher platelet count compared to those with IPSS> 1.5 (138 vs. 58, p <0.001),  as well as in the R-IPSS group <4.5 versus those in the group with R-IPSS> 4.5 (122 vs. 68, p <0.01). 

 

Results

No statistically significant difference in NLR (p <0.087 for IPSS or p <0.112 for R-IPSS) was found. The number of platelets showed a negative correlation with IPSS (rho = -0.500, p <0.001) and R-IPSS (rho = -0.456, p <0.001). Analyzing other parameters, statistically significant correlation of IPSS with LDH (p <0.008) and CRP (p <0.01) was observed. In the IPSS group <1.5 there was a significantly lower LDH level compared to patients with IPSS> 1.5 (189 vs. 233) as well as for CRP (3.25 vs. 11.05) The same observation was for R-IPSS (for LDH 189.5 vs. 227.5, p <0.01, for CRP 2.55 vs 12.1, p <0.002). 

 

Conclusion

In a small number of our patients, we have shown that platelet count, LDH and CRP,  have negative correlation with IPSS and R-IPSS prognostic index.  NLR was not statistically significant, but this should be analyzed on a larger number of MDS patients.

 

Session topic: 10. Myelodysplastic syndromes – Clinical

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies